DEFA14A: Werewolf Therapeutics Sets Date for 2025 Annual Meeting, Outlines Key Proposals

Werewolf Therapeutics, Inc. announces its 2025 Annual Meeting of Shareholders to be held on June 12, 2025, featuring proposals including the election of directors and ratification of the company's accounting firm.

Summary

• Werewolf Therapeutics, Inc. will hold its Annual Meeting on June 12, 2025.
• Shareholders are invited to vote on key proposals.
• The proposals include the election of three Class I directors for a three-year term expiring at the 2028 Annual Meeting.
• The nominees for director are Briggs Morrison, M.D., Michael Sherman, M.B.A., and Anil Singhal, Ph.D.
• Another proposal is the ratification of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025.
• Shareholders can access the proxy materials online or request a copy by May 29, 2025.
• Voting can be done online or virtually at the meeting.

Sentiment

Score: 7

Explanation: The document is a routine announcement of an upcoming shareholder meeting, which is generally neutral to slightly positive as it indicates ongoing corporate governance.

Positives

• Shareholders have multiple options to access proxy materials and vote, including online and virtual participation.
• The company is addressing key governance matters, such as director elections and auditor ratification.

Future Outlook

The document outlines the agenda for the upcoming annual meeting, focusing on corporate governance matters.

Industry Context

This announcement is standard practice for publicly traded companies, ensuring shareholders have the opportunity to participate in key decisions regarding the company's direction and oversight.

Stakeholder Impact

• Shareholders have the opportunity to influence the company's direction through voting.
• The outcome of the director elections and auditor ratification will impact the company's governance and financial oversight.

Next Steps

• Shareholders should review the proxy materials and vote on the proposals.
• The company will hold its Annual Meeting on June 12, 2025.

Key Dates

Keywords

Annual Meeting, Shareholders, Proxy Statement, Directors, Ernst & Young, Voting, Werewolf Therapeutics